STOCK TITAN
  1. Home
  2. News
  3. ELV

Elevance Health, Inc. - ELV STOCK NEWS

Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.

Elevance Health, Inc. (symbol: ELV) is a prominent American health insurance provider, formerly known as Anthem, Inc. until June 2022. As one of the leading health insurers in the United States, Elevance Health delivers medical benefits to approximately 47 million members as of December 2023. The company’s core business revolves around offering a wide range of coverage plans, including employer, individual, and government-sponsored options.

One distinctive feature of Elevance Health is its status as the largest single provider of Blue Cross Blue Shield branded coverage. As the licensee for the Blue Cross Blue Shield Association in 14 states, the company serves a significant portion of the U.S. population. Elevance Health has successfully expanded its offerings through strategic acquisitions, such as the purchase of Amerigroup in 2012 and MMM in 2021. These acquisitions enable the company to broaden its reach and better serve populations enrolled in government-sponsored programs like Medicaid and Medicare Advantage plans.

Elevance Health is committed to improving healthcare accessibility and affordability. The company consistently works on enhancing its services and products to meet the evolving needs of its members. Financially, Elevance Health has maintained a strong position, reflecting robust performance and growth potential.

Recent achievements include the expansion of digital health initiatives and partnerships with healthcare providers to offer more integrated and comprehensive care solutions. With its extensive network and innovative approach, Elevance Health continues to make significant strides in the healthcare industry.

Stay updated with the latest news and developments related to Elevance Health to understand its impact and future direction in the health insurance market.

News

Elevance Health Named in Top 10 of America’s Most JUST Companies by JUST Capital and CNBC

Rhea-AI Summary
Elevance Health (NYSE: ELV) has been ranked #8 on the annual JUST 100 list, recognizing its commitment to serving workers, customers, communities, the environment, and shareholders. The company has been recognized for 6 consecutive years and ranked first in two categories within the healthcare industry. Gail K. Boudreaux, President and CEO, expressed gratitude for the recognition and emphasized the company's commitment to sustainability and driving health equity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.97%
Tags
none
-
News

Elevance Health Reports Results for Fourth Quarter and Full Year 2023; Sets Full Year 2024 Outlook

Rhea-AI Summary
Elevance Health, Inc. (NYSE: ELV) reported a strong financial performance in 4Q 2023 with operating revenue of $42.5 billion, up 7% from 4Q 2022, and FY 2023 operating revenue of $170 billion, up 9.3% from FY 2022. The GAAP diluted EPS1 was $3.63, up 1.1% from 4Q 2022, and adjusted diluted EPS2 was $5.62, up 15.2%. The projected FY 2024 GAAP diluted EPS and adjusted diluted EPS2 are expected to be greater than $34.29 and $37.10 per share, respectively. The quarterly dividend has been increased by 10.1% to $1.63 per share. Operating cash flow for 2023 was $8.1 billion, and the Company repurchased 5.8 million shares of its common stock for $2.7 billion in the same year. The Health Benefits and Carelon segments also reported positive financial results, with increases in operating revenue and operating gain for both the fourth quarter and the full year of 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.32%
Tags
earnings
-
News

Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter Results on January 24, 2024

Rhea-AI Summary
Elevance Health (NYSE: ELV) will release fourth quarter and full year 2023 financial results on January 24, 2024 at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 Access Code - 3972058 (Domestic) 312-470-0178 Access Code - 3972058 (International) 800-568-3942 No Access Code (Domestic Replay) 203-369-3812 No Access Code (International Replay) The replay will be available from 11:30 a.m. EDT on January 24, 2024 until the end of the day on February 23, 2024. The call will also be available through a live webcast at www.elevancehealth.com under the “Investors” link. You may also access the webcast here. A webcast replay will be available following the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
earnings
News

Elevance Health Addresses Healthcare’s Digital Divide by Increasing Access to High-Quality Smartphones and Health-Related Digital Services

Rhea-AI Summary
Elevance Health (ELEV) Announces No-Cost Access to Digital Health Tools Funded by Affordable Connectivity Program
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.62%
Tags
none
-
News

PEAK ROCK CAPITAL AFFILIATE SELLS PARAGON HEALTHCARE, INC. TO ELEVANCE HEALTH

Rhea-AI Summary
Paragon Healthcare, Inc. (NYSE: ELV) has been sold to Elevance Health, an affiliate of Peak Rock Capital, doubling revenues and increasing the number of infusion centers by 400% during Peak Rock's ownership.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.99%
Tags
none
-
News

Elevance Health to Acquire Paragon Healthcare

Rhea-AI Summary
Elevance Health (NYSE: ELV) announced the acquisition of Paragon Healthcare, Inc., specializing in infusible and injectable therapies. Paragon Healthcare provides infusion services through ambulatory infusion centers, home infusion pharmacies, and other specialty pharmacy services. The acquisition aims to provide affordable, convenient access to specialty medications and services for patients with chronic and complex illnesses. Paragon Healthcare serves over 35,000 patients across 8 states and will operate as part of CarelonRx, Elevance Health's health services division. The acquisition is expected to close in the first half of 2024 and is not expected to have a material impact on adjusted earnings per share in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.91%
Tags
acquisition
News

AM Best Affirms Credit Ratings of Elevance Health, Inc. and Its Subsidiaries

Rhea-AI Summary
AM Best Affirms Excellent Ratings for Elevance Health, Inc. (NYSE: ELV) and Subsidiaries
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.41%
Tags
none
-
News

Twenty-One Elevance Health Medicaid Plans Receive NCQA Health Equity Accreditation Plus

Rhea-AI Summary
Elevance Health, Inc. (NYSE: ELV) received the new Health Equity Accreditation Plus for 21 of its affiliated Medicaid plans from the National Committee for Quality Assurance (NCQA), validating its leadership in developing solutions to ensure access to high quality, equitable healthcare. The company's approach to health equity prioritizes the needs of individuals who have been economically and socially marginalized, serving more than 10 million individuals nationwide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
none
-
News

AM Best Assigns Indicative Issue Credit Ratings to Elevance Health, Inc.’s New Shelf Registrations

Rhea-AI Summary
AM Best assigns indicative Long-Term Issue Credit Ratings to Elevance Health, Inc. with a stable outlook, noting the company's ability to manage financial leverage and maintain strong earnings coverage.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
none
News

Elevance Health and AADMD Launch Bold Initiative to Broadly Expand Physician Training on the Care of People with Intellectual and Developmental Disabilities

Rhea-AI Summary
Elevance Health is investing $1.42 million to support the NICHE - Medical project, aimed at making IDD training mainstream in medical schools. Currently, 73% of medical students graduate with no IDD training. Elevance Health has already awarded funds to seven medical schools in 2023, and is accepting proposals for future funding.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.76%
Tags
none

FAQ

What is the current stock price of Elevance Health (ELV)?

The current stock price of Elevance Health (ELV) is $403.6 as of November 21, 2024.

What is the market cap of Elevance Health (ELV)?

The market cap of Elevance Health (ELV) is approximately 93.0B.

What does Elevance Health, Inc. do?

Elevance Health, Inc. is an American health insurance provider offering employer, individual, and government-sponsored coverage plans.

What was Elevance Health, Inc. previously known as?

Prior to June 2022, Elevance Health, Inc. was known as Anthem, Inc.

How many members does Elevance Health serve?

As of December 2023, Elevance Health provides medical benefits to 47 million members.

What makes Elevance Health unique among its peers?

Elevance Health is the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states.

What major acquisitions has Elevance Health completed?

Elevance Health acquired Amerigroup in 2012 and MMM in 2021, expanding its reach in government-sponsored programs like Medicaid and Medicare Advantage.

What types of health plans does Elevance Health offer?

Elevance Health offers employer, individual, and government-sponsored coverage plans, including Medicaid and Medicare Advantage.

How does Elevance Health contribute to improving healthcare?

Elevance Health works on enhancing service accessibility and affordability, incorporating digital health initiatives, and forming partnerships with healthcare providers.

What is the financial condition of Elevance Health?

Elevance Health has maintained a strong financial position, showing robust performance and growth potential.

What recent initiatives has Elevance Health undertaken?

Recent initiatives include the expansion of digital health services and more integrated care solutions through partnerships with healthcare providers.

How can I stay updated on Elevance Health's latest news?

Stay informed by following the latest news and updates about Elevance Health to understand its impact and direction in the health insurance market.

Stock ELV logo
Elevance Health, Inc.

NYSE:ELV

ELV Rankings

#139 Ranked by Market Cap
#1517 Ranked by Dividends

ELV Stock Data

93.02B
231.36M
0.19%
91.42%
1.23%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States of America
INDIANAPOLIS